Your browser doesn't support javascript.
loading
High titer expression of antibodies using linear expression cassettes for early-stage functional screening.
Wu, Shuang; Tsukuda, Joni; Chiang, Nancy; Hao, To; Chen, Yongmei; Hötzel, Isidro; Balasubramanian, Sowmya; Nakamura, Gerald; Kelly, Ryan L.
Afiliação
  • Wu S; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Tsukuda J; Cell Culture and Bioprocess Operations Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Chiang N; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Hao T; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Chen Y; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Hötzel I; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Balasubramanian S; Research Materials Group, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Nakamura G; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
  • Kelly RL; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
Protein Eng Des Sel ; 372024 Jan 29.
Article em En | MEDLINE | ID: mdl-39141844
ABSTRACT
Antibody discovery processes are continually advancing, with an ever-increasing number of potential binding sequences being identified out of in vivo, in vitro, and in silico sources. In this work we describe a rapid system for high yield recombinant antibody (IgG and Fab) expression using Gibson assembled linear DNA fragments (GLFs). The purified recombinant antibody yields from 1 ml expression for this process are approximately five to ten-fold higher than previous methods, largely due to novel usage of protecting flanking sequences on the 5' and 3' ends of the GLF. This method is adaptable for small scale (1 ml) expression and purification for rapid evaluation of binding and activity, in addition to larger scales (30 ml) for more sensitive assays requiring milligram quantities of antibody purified over two columns (Protein A and size exclusion chromatography). When compared to plasmid-based expression, these methods provide nearly equivalent yield of high-quality material across multiple applications, allowing for reduced costs and turnaround times to enhance the antibody discovery process.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Imunoglobulina G / Fragmentos Fab das Imunoglobulinas Limite: Humans Idioma: En Revista: Protein Eng Des Sel Assunto da revista: BIOQUIMICA / BIOTECNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Imunoglobulina G / Fragmentos Fab das Imunoglobulinas Limite: Humans Idioma: En Revista: Protein Eng Des Sel Assunto da revista: BIOQUIMICA / BIOTECNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM